QuidelOrtho Corporation (QDEL)

Market Cap	2.92B
Revenue (ttm)	2.83B
Net Income (ttm)	-1.86B
Shares Out	67.24M
EPS (ttm)	-27.77
PE Ratio	n/a
Forward PE	16.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	631,343
Open	44.60
Previous Close	44.50
Day's Range	42.94 - 45.07
52-Week Range	29.74 - 77.44
Beta	0.08
Analysts	Hold
Price Target	57.50 (+32.34%)
Earnings Date	Oct 30, 2024

About QDEL

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 7,100
• Stock Exchange: NASDAQ
• Ticker Symbol: QDEL
• Website: https://www.quidelortho.com

Analyst Forecast

According to 7 analysts, the average rating for QDEL stock is "Hold." The 12-month stock price forecast is $57.5, which is an increase of 32.34% from the latest price.

Price Target

$57.5

(32.34% upside)

Analyst Consensus: Hold